Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
32 hedge funds and large institutions have $6.09M invested in Pernix Therapeutics Holdings, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
264% more call options, than puts
Call options by funds: $382K | Put options by funds: $105K
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
7% more funds holding
Funds holding: 30 → 32 (+2)
23% less capital invested
Capital invested by funds: $7.93M → $6.09M (-$1.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$146K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$71.9K |
| 3 |
Renaissance Technologies
New York
|
+$60.6K |
| 4 |
Goldman Sachs
New York
|
+$50.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$42.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$241K |
| 2 |
D.E. Shaw & Co
New York
|
-$51K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$33K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$16.8K |
| 5 |
Morgan Stanley
New York
|
-$15.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Bank of America
Charlotte,
North Carolina
| – | -$33K | -8,284 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$5K | -1,236 | Closed |
|
28
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$963 | -300 | -100% |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$16 | +5 | +56% |
|
|
VNA
30
Valley National Advisers
Bethlehem,
Pennsylvania
| – | +$19 | +6 | New |
|
PTX Hedge Fund Activity: Q3 2017 in Review
32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2017, worth a combined $6.09M — down 23% from $7.93M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PTX positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was California Public Employees Retirement System, adding an estimated $146K. The largest seller was Vanguard Group, cutting an estimated $241K.
- 32 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2017, up from 30 in Q2 2017.
- Funds reported $6.09M of Pernix Therapeutics Holdings, Inc. stock for Q3 2017, down 23% quarter-over-quarter.
- 7 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2017 and 4 closed out, a net change of +3 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2017 was California Public Employees Retirement System, an estimated $146K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2017 was Vanguard Group, an estimated $241K sold.
Based on aggregated 13F filings for Q3 2017.